145 related articles for article (PubMed ID: 9456687)
21. IL-17C and its receptor IL-17RA/IL-17RE identify human oral epithelial cell as an inflammatory cell in recurrent aphthous ulcer.
Al-Samadi A; Kouri VP; Salem A; Ainola M; Kaivosoja E; Barreto G; Konttinen YT; Hietanen J; Häyrinen-Immonen R
J Oral Pathol Med; 2014 Feb; 43(2):117-24. PubMed ID: 23834281
[TBL] [Abstract][Full Text] [Related]
22. Toll-like receptor activity in recurrent aphthous ulceration.
Borra RC; de Mesquita Barros F; de Andrade Lotufo M; Villanova FE; Andrade PM
J Oral Pathol Med; 2009 Mar; 38(3):289-98. PubMed ID: 19267841
[TBL] [Abstract][Full Text] [Related]
23. Thalidomide in the management of recurrent aphthous ulcerations in patients who are HIV-positive: a review and case reports.
Shetty K
Spec Care Dentist; 2005; 25(5):236-41. PubMed ID: 16454100
[TBL] [Abstract][Full Text] [Related]
24. [Effects of dihydromyricetin on tumor necrosis factor and NF-kappaB p65 of RAU rats].
Yang XM; Wang XH; Chen LF; Wang XQ
Zhongguo Zhong Yao Za Zhi; 2012 Sep; 37(17):2612-7. PubMed ID: 23236762
[TBL] [Abstract][Full Text] [Related]
25. [Cytomegalovirus infection and the changes of T-lymphocyte subsets in RAU patients].
Xiang X; Liu J; Li H
Zhonghua Kou Qiang Yi Xue Za Zhi; 2000 May; 35(3):212-4. PubMed ID: 11780228
[TBL] [Abstract][Full Text] [Related]
26. Expression of Th1/Th2/Th3/Th17-related genes in recurrent aphthous ulcers.
Lewkowicz N; Kur B; Kurnatowska A; Tchorzewski H; Lewkowicz P
Arch Immunol Ther Exp (Warsz); 2011 Oct; 59(5):399-406. PubMed ID: 21805152
[TBL] [Abstract][Full Text] [Related]
27. [Soluble programmed death-1 and soluble programmed death ligand 1 protein expression and immune status in patients with recurrent aphthous ulcer].
Nan J; Liang L; Li L; Xiaoqin S; Xing J; Yang C
Hua Xi Kou Qiang Yi Xue Za Zhi; 2017 Jun; 35(3):286-290. PubMed ID: 28675014
[TBL] [Abstract][Full Text] [Related]
28. Lymphocyte function in patients with recurrent aphthous ulcers.
Sun A; Wu YC; Kwan HW
Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1987 Aug; 20(3):204-9. PubMed ID: 3428014
[TBL] [Abstract][Full Text] [Related]
29. Natural immunity in recurrent aphthous ulceration.
Sistig S; Cekic-Arambasin A; Rabatic S; Vucicevic-Boras V; Kleinheinz J; Piffko J
J Oral Pathol Med; 2001 May; 30(5):275-80. PubMed ID: 11334463
[TBL] [Abstract][Full Text] [Related]
30. Hematologic abnormalities in recurrent oral ulceration.
Thongprasom K; Youngnak P; Aneksuk V
Southeast Asian J Trop Med Public Health; 2002 Dec; 33(4):872-7. PubMed ID: 12757242
[TBL] [Abstract][Full Text] [Related]
31. Serum vitamin B12, folate, and iron levels in recurrent aphthous ulceration.
Olson JA; Feinberg I; Silverman S; Abrams D; Greenspan JS
Oral Surg Oral Med Oral Pathol; 1982 Nov; 54(5):517-20. PubMed ID: 6960305
[TBL] [Abstract][Full Text] [Related]
32. Expression of laminin 5, fibronectin, and epithelium-associated integrins in recurrent aphthous ulcers.
Richards DW; MacPhail LA; Dekker N; Greenspan D; Greenspan JS; Lozada-Nur F; Regezi JA
J Dent Res; 1996 Jul; 75(7):1512-7. PubMed ID: 8876604
[TBL] [Abstract][Full Text] [Related]
33. Increased production of tumour necrosis factor by peripheral blood leukocytes in patients with recurrent oral aphthous ulceration.
Taylor LJ; Bagg J; Walker DM; Peters TJ
J Oral Pathol Med; 1992 Jan; 21(1):21-5. PubMed ID: 1593490
[TBL] [Abstract][Full Text] [Related]
34. Assessment of salivary and serum antioxidant vitamins and lipid peroxidation in patients with recurrent aphthous ulceration.
Saral Y; Coskun BK; Ozturk P; Karatas F; Ayar A
Tohoku J Exp Med; 2005 Aug; 206(4):305-12. PubMed ID: 15997201
[TBL] [Abstract][Full Text] [Related]
35. Oral ulcerations in HIV infection.
Reichart PA
Oral Dis; 1997 May; 3 Suppl 1():S180-2. PubMed ID: 9456685
[TBL] [Abstract][Full Text] [Related]
36. A study of macrophages, macrophage-related cells, and endothelial adhesion molecules in recurrent aphthous ulcers in HIV-positive patients.
Regezi JA; Macphail LA; Richards DW; Greenspan JS
J Dent Res; 1993 Dec; 72(12):1549-53. PubMed ID: 7504704
[TBL] [Abstract][Full Text] [Related]
37. [Alteration of Th17 cells, immunoglobins and complements levels in peripheral blood of patients with refractory recurrent aphthous ulcer].
Yang LL; Wang WM; Liu YJ; Jiang TW; Wang BL
Shanghai Kou Qiang Yi Xue; 2017 Oct; 26(5):521-525. PubMed ID: 29308514
[TBL] [Abstract][Full Text] [Related]
38. Psychological status and recurrent aphthous ulceration.
Picek P; Buljan D; Rogulj AA; Stipetić-Ovcarićek J; Catić A; Plestina S; Boras VV; Vidović-Juras D
Coll Antropol; 2012 Mar; 36(1):157-9. PubMed ID: 22816214
[TBL] [Abstract][Full Text] [Related]
39. Risk indicators for recurrent aphthous ulcers among adults in the US.
Chattopadhyay A; Chatterjee S
Community Dent Oral Epidemiol; 2007 Apr; 35(2):152-9. PubMed ID: 17331156
[TBL] [Abstract][Full Text] [Related]
40. Quantitative assessment of mast cells in recurrent aphthous ulcers (RAU).
Natah SS; Häyrinen-Immonen R; Hietanen J; Malmström M; Konttinen YT
J Oral Pathol Med; 1998 Mar; 27(3):124-9. PubMed ID: 9563804
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
